Maria Magdalena Georgescu

Affiliations: 
2013-2015 Pathology University of Texas Southwestern Medical Center, Dallas, TX, United States 
Google:
"Maria Georgescu"
Mean distance: 18.08 (cluster 32)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Georgescu MM, Olar A. (2020) Genetic and histologic spatiotemporal evolution of recurrent, multifocal, multicentric and metastatic glioblastoma. Acta Neuropathologica Communications. 8: 10
Georgescu MM, Mobley BC, Orr BA, et al. (2016) NHERF1/EBP50 and NF2 as diagnostic markers for choroid plexus tumors. Acta Neuropathologica Communications. 4: 55
Georgescu MM, Pinho Mda C, Richardson TE, et al. (2015) The defining pathology of the new clinical and histopathologic entity ACTA2-related cerebrovascular disease. Acta Neuropathologica Communications. 3: 81
Georgescu MM, Yell P, Mobley BC, et al. (2015) NHERF1/EBP50 is an organizer of polarity structures and a diagnostic marker in ependymoma. Acta Neuropathologica Communications. 3: 11
Georgescu MM, Cote G, Agarwal NK, et al. (2014) NHERF1/EBP50 controls morphogenesis of 3D colonic glands by stabilizing PTEN and ezrin-radixin-moesin proteins at the apical membrane. Neoplasia (New York, N.Y.). 16: 365-74.e1-2
Agarwal NK, Zhu X, Gagea M, et al. (2014) PHLPP2 suppresses the NF-κB pathway by inactivating IKKβ kinase. Oncotarget. 5: 815-23
Navalkele DD, Georgescu MM, Burns DK, et al. (2013) Progressive leg pain and weakness. Jama Neurology. 70: 510-4
Molina JR, Agarwal NK, Morales FC, et al. (2012) PTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastoma. Oncogene. 31: 1264-74
Georgescu MM. (2010) PTEN Tumor Suppressor Network in PI3K-Akt Pathway Control. Genes & Cancer. 1: 1170-7
Hayashi Y, Molina JR, Hamilton SR, et al. (2010) NHERF1/EBP50 is a new marker in colorectal cancer. Neoplasia (New York, N.Y.). 12: 1013-22
See more...